Canakinumab in Patients With Active Hyper-IgD Syndrome
Clinical trial NCT01303380 · COMPLETED
Trial details
- NCT number
- NCT01303380
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.